Side Effects of Cancer Therapy: Prevention and Treatment
Editat de Mario A. Dicato, Eric Van Cutsemen Limba Engleză Hardback – 16 oct 2025
The reader will learn about the state of the art in cancer therapies and their side-effects as well as possible prevention. Chapters remain up to date via electronic updates and include all the latest progress in drug discovery, surgery and radiotherapy.
This is a very comprehensive work written by a team of world experts and edited by key opinion leaders. This book is aimed at medical, surgical and clinical oncologists but is a great resource for junior doctors, trainees, pharmacists and nurses.
Preț: 3496.50 lei
Preț vechi: 3680.52 lei
-5% Nou
Puncte Express: 5245
Preț estimativ în valută:
670.24€ • 703.45$ • 552.78£
670.24€ • 703.45$ • 552.78£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031472749
ISBN-10: 3031472748
Ilustrații: X, 990 p. 200 illus., 100 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:3rd ed. 2025
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3031472748
Ilustrații: X, 990 p. 200 illus., 100 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:3rd ed. 2025
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Side Effects of Medical Cancer Therapy.- Drug Interactions and Pharmacogenetics.- Breast Cancer.- Lung Cancer.- Gastrointestinal Cancer: Selection of Clinically Relevant Drug-Induced Toxicities Encountered in Gastrointestinal Cancer Treatment.- Gynecologic Cancer.- Side Effects of Medical Cancer Therapy in Genitourinary Malignancies.- Central Nervous System.- Myeloid Malignancies.- Lymphoma.- Multiple Myeloma.- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy.- Immune Checkpoint Inhibition.- Preservation of Fertility in the Cancer Patient.- Cardiotoxicity.- Bone Marrow Toxicity: Red Blood Cells.- Bone Marrow Toxicity: White Blood Cells..- Bone Marrow Toxicity: Platelets.- Toxicity of Bone-Targeted Agents in Malignancy.- State of the Art of Antiemetic Therapy.- Side Effects of Nociceptive Cancer Pain Treatments in Adults.- Totally Implanted Access Ports: Indications and Prevention of Complications.- Side Effects of Surgical Cancer Therapy.- Neurosurgery.- Oro-Maxillo-Facial.- Thoracic surgery.- Thoracic surgery.- Thoracic surgery: Breast.- Thoracic surgery: Endocrine.- Abdominal surgery: Gastric.- Abdominal surgery: Hepatobiliary.- Abdominal surgery: Pancreas.- Abdominal surgery: Colorectal surgery including Peritonectomy.- Abdominal surgery: Urology.- Abdominal surgery: Gynecology.- Abdominal surgery: Orthopedics/sarcoma.- Melanoma.- Side Effects of Radiotherapy.- What is radiotherapy, a general introduction.- The place of radiotherapy in cancer treatment.- Radiotherapy concepts and planning.- The different types of radiotherapy.- External beam radiotherapy: Photons.- External beam radiotherapy: Electrons.- External beam radiotherapy: Particles.- Brachytherapy.- Radiobiology: DNA damage and cell death.- Radiobiology: Cell survival curve.- Radiobiology: Dose response relationship and therapeutic window.- Radiobiology: Therapeutic ratio and window.- Radiobiology: The ‘R’ in radiotherapy.- Factors in tissue responds to irradiation.- Dose-Volume Relationship.- Dose-Volume histogram.- Serial and Parallel Organs.
Notă biografică
Mario Dicato, Hematology-Oncology Service at Luxembourg Medical Center, Luxembourg, and Head of the Research Laboratory of the Luxembourg Foundation for Research on Cancer and Blood Disorders. M. Dicato trained at Lausanne University, completed his postgraduate training at the Universities of Geneva, Switzerland, Pittsburgh and Yale, USA. He did his fellowship (subspecialty training) in hematology at the Massachusetts General Hospital, Boston and was Clinical and Research Fellow in Medicine at Harvard University, Boston, USA.
Karin Haustermans is Chair of the Department of Radiation Oncology at the Leuven Cancer Institute of the University Hospital Gasthuisberg (Belgium) and a Full Professor at the KU Leuven. She is specialized in GI and GU oncology and has a part time research appointment as a Fundamental, Clinical Researcher that is sponsored by the Research Foundation – Flanders. She is also a member of several (inter)national scientific organizations. From 2006 to 2009 she held the Chair of the EORTC Radiation Oncology Group and from 2009 until 2015 she was Chair of the Quality Assurance Committee of EORTC. She is also heavily involved in the Belgian Cancer Registry as a member of the board and Chair of the Coordination Council. She is member of the scientific board of OncoRay Dresden and Helmholtz- Zentrum Dresden-Rossendorf (operational proton facility) and member of the scientific advisory committee of CERN (Geneva). In 2009 she was awarded the ESTRO Breur medal in recognition of her major contribution to European Radiotherapy. From 2011 onwards she was elected as a member of the Royal Academy of Medicine and in 2015 she was elected as a fellow of the European Academy of Cancer Sciences.
Eric Van Cutsem, MD, PhD, is full professor and Head of the division of Digestive Oncology at University of Leuven, Leuven, Belgium (KUL) and University Hospitals Leuven. He became in 2018 doctor honoris causa of the Medical University of Warsaw, Poland. He is member of the Belgian Royal Academy of Medicine and president of the Belgian Foundation against Cancer and received in 2019 the ESMO Award. His research focuses on the development of new treatment strategies for GI cancers, including drug development and the identification of molecular markers and diagnostic tools. He has published more than 560 peer-reviewed articles, leading to more than 68500 citations and an H-Factor of 118. In 2013, Capital magazine ranked Prof Van Cutsem in the top three reputed colon cancer experts globally. Thomson Reuters ranks him in the top 1% for impact in his domain. He co-founded the ESMO GI/World Congress on Gastrointestinal Cancer, and is Chair of the meeting in Barcelona, Spain. He serves/served on the board or key committee of several international societies, including ESMO, ASCO, ENET, EORTC, ECCO, ESDO and of the patient advocacy groups, Europacolon and Digestive Cancers Europe
Karin Haustermans is Chair of the Department of Radiation Oncology at the Leuven Cancer Institute of the University Hospital Gasthuisberg (Belgium) and a Full Professor at the KU Leuven. She is specialized in GI and GU oncology and has a part time research appointment as a Fundamental, Clinical Researcher that is sponsored by the Research Foundation – Flanders. She is also a member of several (inter)national scientific organizations. From 2006 to 2009 she held the Chair of the EORTC Radiation Oncology Group and from 2009 until 2015 she was Chair of the Quality Assurance Committee of EORTC. She is also heavily involved in the Belgian Cancer Registry as a member of the board and Chair of the Coordination Council. She is member of the scientific board of OncoRay Dresden and Helmholtz- Zentrum Dresden-Rossendorf (operational proton facility) and member of the scientific advisory committee of CERN (Geneva). In 2009 she was awarded the ESTRO Breur medal in recognition of her major contribution to European Radiotherapy. From 2011 onwards she was elected as a member of the Royal Academy of Medicine and in 2015 she was elected as a fellow of the European Academy of Cancer Sciences.
Eric Van Cutsem, MD, PhD, is full professor and Head of the division of Digestive Oncology at University of Leuven, Leuven, Belgium (KUL) and University Hospitals Leuven. He became in 2018 doctor honoris causa of the Medical University of Warsaw, Poland. He is member of the Belgian Royal Academy of Medicine and president of the Belgian Foundation against Cancer and received in 2019 the ESMO Award. His research focuses on the development of new treatment strategies for GI cancers, including drug development and the identification of molecular markers and diagnostic tools. He has published more than 560 peer-reviewed articles, leading to more than 68500 citations and an H-Factor of 118. In 2013, Capital magazine ranked Prof Van Cutsem in the top three reputed colon cancer experts globally. Thomson Reuters ranks him in the top 1% for impact in his domain. He co-founded the ESMO GI/World Congress on Gastrointestinal Cancer, and is Chair of the meeting in Barcelona, Spain. He serves/served on the board or key committee of several international societies, including ESMO, ASCO, ENET, EORTC, ECCO, ESDO and of the patient advocacy groups, Europacolon and Digestive Cancers Europe
Textul de pe ultima copertă
The third edition of this book has been extensively expanded to discuss all aspects of cancer treatment side-effects in everyday life, covering a range of issues from skin problems to fertility problems, Divided in three major parts, the first part covers medical cancer therapy side effects, ranging from organ-related toxicities to drug group particularities. In the second part the adverse events in surgery are extensively discussed, covering issues in regular and robotic surgery and discussing indications and effectiveness. Finally, in the third part, the balance of efficacy versus toxicity in radiotherapy is discussed for different tumor types.
The reader will learn about the state of the art in cancer therapies and their side-effects as well as possible prevention. Chapters remain up to date via electronic updates and include all the latest progress in drug discovery, surgery and radiotherapy.
This is a very comprehensive work written by a team of world experts and edited by key opinion leaders. This book is aimed at medical, surgical and clinical oncologists but is a great resource for junior doctors, trainees, pharmacists and nurses.
The reader will learn about the state of the art in cancer therapies and their side-effects as well as possible prevention. Chapters remain up to date via electronic updates and include all the latest progress in drug discovery, surgery and radiotherapy.
This is a very comprehensive work written by a team of world experts and edited by key opinion leaders. This book is aimed at medical, surgical and clinical oncologists but is a great resource for junior doctors, trainees, pharmacists and nurses.
Caracteristici
Updated medical, surgical and clinical oncology side effects Covers the state-of-the-art therapies Shows methods of prevention and/or treatment